204 related articles for article (PubMed ID: 7831418)
1. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
[TBL] [Abstract][Full Text] [Related]
2. Absence of amnestic effect of an anxiolytic 5-HT3 antagonist (BRL 46470A) injected into basolateral amygdala, as opposed to diazepam.
de Souza Silva M; Guimarães FS; Graeff FG; Tomaz C
Behav Brain Res; 1993 Dec; 59(1-2):141-5. PubMed ID: 8155281
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic activity of Y-25130 on 5-HT3 receptors.
Sato N; Sakamori M; Haga K; Takehara S; Setoguchi M
Jpn J Pharmacol; 1992 Aug; 59(4):443-8. PubMed ID: 1331590
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
Gao B; Cutler MG
Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
[TBL] [Abstract][Full Text] [Related]
6. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
[TBL] [Abstract][Full Text] [Related]
7. Increased gut cholinergic activity and antagonism of 5-hydroxytryptamine M-receptors by BRL 24924: potential clinical importance of BRL 24924.
Sanger GJ
Br J Pharmacol; 1987 May; 91(1):77-87. PubMed ID: 3594084
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
Waikar MV; Hegde SS; Ford AP; Clarke DE
J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
[TBL] [Abstract][Full Text] [Related]
11. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
[TBL] [Abstract][Full Text] [Related]
12. Prolonged anti-emetic activity and 5-HT3-receptor antagonism by BRL 46470 in conscious ferrets.
Bermudez J; Sanger GJ
J Pharm Pharmacol; 1994 Jun; 46(6):520-1. PubMed ID: 7932054
[TBL] [Abstract][Full Text] [Related]
13. The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.
Silverstone PH; Cowen PJ
Biol Psychiatry; 1994 Sep; 36(5):309-16. PubMed ID: 7993957
[TBL] [Abstract][Full Text] [Related]
14. Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).
Sanger GJ; Nelson DR
Eur J Pharmacol; 1989 Jan; 159(2):113-24. PubMed ID: 2540014
[TBL] [Abstract][Full Text] [Related]
15. 5-HT3 receptor antagonists. 2. 4-Hydroxy-3-quinolinecarboxylic acid derivatives.
Hayashi H; Miwa Y; Ichikawa S; Yoda N; Miki I; Ishii A; Kono M; Yasuzawa T; Suzuki F
J Med Chem; 1993 Mar; 36(5):617-26. PubMed ID: 8496941
[TBL] [Abstract][Full Text] [Related]
16. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
17. BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors.
Newberry NR; Watkins CJ; Sprosen TS; Blackburn TP; Grahame-Smith DG; Leslie RA
Neuropharmacology; 1993 Aug; 32(8):729-35. PubMed ID: 8413836
[TBL] [Abstract][Full Text] [Related]
18. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
19. Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.
Heidempergher F; Pillan A; Pinciroli V; Vaghi F; Arrigoni C; Bolis G; Caccia C; Dho L; McArthur R; Varasi M
J Med Chem; 1997 Oct; 40(21):3369-80. PubMed ID: 9341912
[TBL] [Abstract][Full Text] [Related]
20. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
Langlois A; Pascaud X; Junien JL; Dahl SG; Rivière PJ
Eur J Pharmacol; 1996 Dec; 318(1):141-4. PubMed ID: 9007525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
